Earlier this week our cannabis attorneys Austin Ownbey and Regina DeSantis were joined by special guest Darrell Carrington from Carrington & Associates, LLC for a webinar to discuss the Maryland Round 1 application process.
Key Takeaways:
The New York Cannabis Control Board (the “CCB”) has extended the window for adult-use cannabis license applications by two weeks. The announcement came during the CCB hearing on Tuesday, October 17th. The new deadline to apply for expedited final Retail Dispensary and Microbusiness licenses has been extended to 5:00pm on November 17th, and the deadline
Key Takeaways:
As readers of this blog are well aware, the uncertainty surrounding the legality and enforceability of Massachusetts’ “Community Impact Fees,” most recently addressed by An Act Relative to Equity in the Cannabis Industry (“the Act”), which took effect in November of 2022, has led to much consternation in the industry and, in several cases, lawsuits
Key Takeaways:
On Friday, September 8, the Maryland Cannabis Administration (MCA) Office of Social Equity released additional information for its upcoming initial licensing round, including the social equity verification portal, application timeframe and deadlines, and the number of licenses available per county. The first round of licensing is limited to Social Equity Applicants.
Social Equity Verification Portal
Potential
As will be discussed in greater detail by the Foley Hoag’s cannabis practice team on its webinar scheduled for September 13, 2023, the New York Cannabis Control Board (“CCB”) and Office of Cannabis Management (“OCM”) took substantial and meaningful steps to open up the full-adult use market in short order. As many may be
On September 8, 2023, the Cannabis Control Commission (“CCC”) held a hearing to discuss its proposed regulations, which were published in the Massachusetts Register on August 16. The regulations, which we discussed in a previous post here, fundamentally change the rules regarding Host Community Agreements (“HCAs”). The new regulations, if adopted as expected, will:
As previously discussed by Foley Hoag’s attorneys in its Cannabis practice, a rescheduling of cannabis from a Schedule I Controlled Substance to a Schedule III Controlled Substance will provide cannabis businesses with the ability to claim tax deductions and a host of other potential benefits, but it most likely will not open the courthouse
Will the United States Attorney General, via the U.S. Drug Enforcement Administration (“DEA”) follow the recent recommendation of the U.S. Department of Health
and Human Services (“HHS”) to reschedule cannabis to Schedule III? The plain language in the United States Controlled Substances Act (the “CSA”) compels DEA to do so, but there is speculation that